SWEET MAGNOLIA THERAPEUTICS Trademark

Trademark Overview


On Wednesday, April 6, 2022, a trademark application was filed for SWEET MAGNOLIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SWEET MAGNOLIA THERAPEUTICS trademark a serial number of 97349053. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Wednesday, January 22, 2025. This trademark is owned by Sweet Magnolia Therapeutics, Inc.. The SWEET MAGNOLIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof, namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from hemp-derived CBD and having less than .3% THC; promotional items, n...
sweet magnolia therapeutics

General Information


Serial Number97349053
Word MarkSWEET MAGNOLIA THERAPEUTICS
Filing DateWednesday, April 6, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof, namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from hemp-derived CBD and having less than .3% THC; promotional items, namely, apparel, pens, pencils, mugs, cups, and water bottles

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSweet Magnolia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontgomery, AL 36104

Trademark Events


Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023ASSIGNED TO EXAMINER
Friday, January 27, 2023ASSIGNED TO EXAMINER
Monday, August 14, 2023ASSIGNED TO EXAMINER
Wednesday, August 16, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 16, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 16, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 16, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, February 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2024FINAL REFUSAL WRITTEN
Thursday, February 22, 2024FINAL REFUSAL E-MAILED
Thursday, February 22, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, October 5, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, October 5, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 5, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 21, 2025ASSIGNED TO PETITION STAFF
Wednesday, January 22, 2025NOTICE OF REVIVAL - E-MAILED
Wednesday, January 22, 2025PETITION GRANTED - RESPONSE RECEIVED